Search Results - "Berclaz, Pierre-Yves" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

A Phase II Randomized Study of Subcutaneous Ixekizumab, an Anti–Interleukin‐17 Monoclonal Antibody, in Rheumatoid Arthritis Patients Who Were Naive to Biologic Agents or Had an Inadequate Response to Tumor Necrosis Factor Inhibitors

A Phase II Randomized Study of Subcutaneous Ixekizumab, an Anti–Interleukin‐17 Monoclonal Antibody, in Rheumatoid Arthritis Patients Who Were Naive to Biologic Agents or Had an Inadequate Response to Tumor Necrosis Factor Inhibitors

by Genovese, Mark C., Greenwald, Maria, Cho, Chul‐Soo, Berman, Alberto, Jin, Ling, Cameron, Gregory S., Benichou, Olivier, Xie, Li, Braun, Daniel, Berclaz, Pierre‐Yves, Banerjee, Subhashis
Published in Arthritis & rheumatology (Hoboken, N.J.) (01.07.2014)

Get full text

Journal Article

GM-CSF Autoantibodies and Neutrophil Dysfunction in Pulmonary Alveolar Proteinosis

GM-CSF Autoantibodies and Neutrophil Dysfunction in Pulmonary Alveolar Proteinosis

by Uchida, Kanji, Beck, David C, Yamamoto, Takashi, Berclaz, Pierre-Yves, Abe, Shuichi, Staudt, Margaret K, Carey, Brenna C, Filippi, Marie-Dominique, Wert, Susan E, Denson, Lee A, Puchalski, Jonathan T, Hauck, Diane M, Trapnell, Bruce C
Published in The New England journal of medicine (08.02.2007)

Get full text

Journal Article

Safety and efficacy of baricitinib at 24 weeks in patients with rheumatoid arthritis who have had an inadequate response to methotrexate

Safety and efficacy of baricitinib at 24 weeks in patients with rheumatoid arthritis who have had an inadequate response to methotrexate

by Keystone, Edward C, Taylor, Peter C, Drescher, Edit, Schlichting, Douglas E, Beattie, Scott D, Berclaz, Pierre-Yves, Lee, Chin H, Fidelus-Gort, Rosanne K, Luchi, Monica E, Rooney, Terence P, Macias, William L, Genovese, Mark C
Published in Annals of the rheumatic diseases (01.02.2015)

Get full text

Journal Article

AIR Inhaled Insulin Versus Subcutaneous Insulin

AIR Inhaled Insulin Versus Subcutaneous Insulin

by Wolzt, Michael, de la Peña, Amparo, Berclaz, Pierre-Yves, Tibaldi, Fabián S., Gates, Jeffrey R., Muchmore, Douglas B.
Published in Diabetes care (01.04.2008)

Get full text

Journal Article

Standardized procedure for measurement of nasal potential difference: An outcome measure in multicenter cystic fibrosis clinical trials

Standardized procedure for measurement of nasal potential difference: An outcome measure in multicenter cystic fibrosis clinical trials

by Standaert, Thomas A., Boitano, Louis, Emerson, Julia, Milgram, Laura J.H., Konstan, Michael W., Hunter, Janice, Berclaz, Pierre-Yves, Brass, Lois, Zeitlin, Pamela L., Hammond, Keith, Davies, Zoe, Foy, Carla, Noone, Peadar G., Knowles, Michael R.
Published in Pediatric pulmonology (01.05.2004)

Get full text

Journal Article

A phase 2 dose-ranging study of subcutaneous tabalumab for the treatment of patients with active rheumatoid arthritis and an inadequate response to methotrexate

A phase 2 dose-ranging study of subcutaneous tabalumab for the treatment of patients with active rheumatoid arthritis and an inadequate response to methotrexate

by Genovese, Mark C, Lee, Eric, Satterwhite, Julie, Veenhuizen, Melissa, Disch, Damon, Berclaz, Pierre-Yves, Myers, Stephen, Sides, Gregory, Benichou, Olivier
Published in Annals of the rheumatic diseases (01.09.2013)

Get full text

Journal Article

Relationship Between Vertebral Fracture Burden, Height Loss, and Pulmonary Function in Postmenopausal Women With Osteoporosis

Relationship Between Vertebral Fracture Burden, Height Loss, and Pulmonary Function in Postmenopausal Women With Osteoporosis

by Krege, John H, Kendler, David, Krohn, Kelly, Genant, Harry, Alam, Jahangir, Berclaz, Pierre-Yves, Coffey, Barbara, Loghin, Corina
Published in Journal of clinical densitometry (01.10.2015)

Get more information

Journal Article

Safety and Efficacy of Open-label Subcutaneous Ixekizumab Treatment for 48 Weeks in a Phase II Study in Biologic-naive and TNF-IR Patients with Rheumatoid Arthritis

Safety and Efficacy of Open-label Subcutaneous Ixekizumab Treatment for 48 Weeks in a Phase II Study in Biologic-naive and TNF-IR Patients with Rheumatoid Arthritis

by Genovese, Mark C, Braun, Daniel K, Erickson, Janelle S, Berclaz, Pierre-Yves, Banerjee, Subhashis, Heffernan, Michael P, Carlier, Hilde
Published in Journal of rheumatology (01.02.2016)

Get more information

Journal Article

Tabalumab, an anti-BAFF monoclonal antibody, in patients with active rheumatoid arthritis with an inadequate response to TNF inhibitors

Tabalumab, an anti-BAFF monoclonal antibody, in patients with active rheumatoid arthritis with an inadequate response to TNF inhibitors

by Genovese, Mark C, Fleischmann, Roy M, Greenwald, Maria, Satterwhite, Julie, Veenhuizen, Melissa, Xie, Li, Berclaz, Pierre-Yves, Myers, Stephen, Benichou, Olivier
Published in Annals of the rheumatic diseases (01.09.2013)

Get full text

Journal Article

Endocytic Internalization of Adenovirus, Nonspecific Phagocytosis, and Cytoskeletal Organization Are Coordinately Regulated in Alveolar Macrophages by GM-CSF and PU.1

Endocytic Internalization of Adenovirus, Nonspecific Phagocytosis, and Cytoskeletal Organization Are Coordinately Regulated in Alveolar Macrophages by GM-CSF and PU.1

by Berclaz, Pierre-Yves, Zsengeller, Zsuzsanna, Shibata, Yoko, Otake, Kazuhisa, Strasbaugh, Steven, Whitsett, Jeffrey A, Trapnell, Bruce C
Published in The Journal of immunology (1950) (01.12.2002)

Get full text

Journal Article

GM-CSF Regulates Alveolar Macrophage Differentiation and Innate Immunity in the Lung through PU.1

GM-CSF Regulates Alveolar Macrophage Differentiation and Innate Immunity in the Lung through PU.1

by Shibata, Yoko, Berclaz, Pierre-Yves, Chroneos, Zissis C, Yoshida, Mitsuhiro, Whitsett, Jeffrey A, Trapnell, Bruce C
Published in Immunity (Cambridge, Mass.) (01.10.2001)

Get full text

Journal Article

A 52-week, open-label study evaluating the safety and efficacy of tabalumab, an anti-B-cell-activating factor monoclonal antibody, for rheumatoid arthritis

A 52-week, open-label study evaluating the safety and efficacy of tabalumab, an anti-B-cell-activating factor monoclonal antibody, for rheumatoid arthritis

by Greenwald, Maria, Szczepanski, Leszek, Kennedy, Alastair, Veenhuizen, Melissa, Komocsar, Wendy J, Polasek, Emery, Guerrettaz, Kelly, Berclaz, Pierre-Yves, Lee, Chin
Published in Arthritis research & therapy (29.08.2014)

Get full text

Journal Article

Rho GTPase Rac1 is critical for neutrophil migration into the lung

Rho GTPase Rac1 is critical for neutrophil migration into the lung

by Filippi, Marie-Dominique, Szczur, Kathleen, Harris, Chad E., Berclaz, Pierre-Yves
Published in Blood (01.02.2007)

Get full text

Journal Article

GM-CSF, via PU.1, regulates alveolar macrophage FcγR-mediated phagocytosis and the IL-18/IFN-γ–mediated molecular connection between innate and adaptive immunity in the lung

GM-CSF, via PU.1, regulates alveolar macrophage FcγR-mediated phagocytosis and the IL-18/IFN-γ–mediated molecular connection between innate and adaptive immunity in the lung

by Berclaz, Pierre-Yves, Shibata, Yoko, Whitsett, Jeffrey A., Trapnell, Bruce C.
Published in Blood (01.12.2002)

Get full text

Journal Article

GM-CSF Regulates a PU.1-Dependent Transcriptional Program Determining the Pulmonary Response to LPS

GM-CSF Regulates a PU.1-Dependent Transcriptional Program Determining the Pulmonary Response to LPS

by Berclaz, Pierre-Yves, Carey, Brenna, Fillipi, Marie-Dominique, Wernke-Dollries, Kara, Geraci, Nick, Cush, Stephanie, Richardson, Terry, Kitzmiller, Joe, O'Connor, Michael, Hermoyian, Christina, Korfhagen, Thomas, Whitsett, Jeffrey A, Trapnell, Bruce C
Published in American journal of respiratory cell and molecular biology (01.01.2007)

Get full text

Journal Article

Efficacy and Safety of Tabalumab, an Anti-B-Cell-Activating Factor Monoclonal Antibody, in a Heterogeneous Rheumatoid Arthritis Population: Results From a Randomized, Placebo-Controlled, Phase 3 Trial (FLEX-O)

Efficacy and Safety of Tabalumab, an Anti-B-Cell-Activating Factor Monoclonal Antibody, in a Heterogeneous Rheumatoid Arthritis Population: Results From a Randomized, Placebo-Controlled, Phase 3 Trial (FLEX-O)

by Genovese, Mark C, Silverman, Gregg J, Emery, Paul, Gupta, Ramesh C, Gill, Anne, Veenhuizen, Melissa, Xie, Li, Komocsar, Wendy J, Berclaz, Pierre-Yves, Lee, Chin
Published in Journal of clinical rheumatology (01.08.2015)

Get more information

Journal Article

Efficacy and safety of tabalumab, an anti-BAFF monoclonal antibody, in patients with moderate-to-severe rheumatoid arthritis and inadequate response to TNF inhibitors: results of a randomised, double-blind, placebo-controlled, phase 3 study

Efficacy and safety of tabalumab, an anti-BAFF monoclonal antibody, in patients with moderate-to-severe rheumatoid arthritis and inadequate response to TNF inhibitors: results of a randomised, double-blind, placebo-controlled, phase 3 study

by Schiff, Michael, Combe, Bernard, Dörner, Thomas, Kremer, Joel M, Huizinga, Thomas W, Veenhuizen, Melissa, Gill, Anne, Komocsar, Wendy, Berclaz, Pierre-Yves, Ortmann, Robert, Lee, Chin
Published in Rheumatic & musculoskeletal diseases open (01.01.2015)

Get full text

Journal Article

Internalization of Adenovirus by Alveolar Macrophages Initiates Early Proinflammatory Signaling during Acute Respiratory Tract Infection

Internalization of Adenovirus by Alveolar Macrophages Initiates Early Proinflammatory Signaling during Acute Respiratory Tract Infection

by Zsengellér, Z, Otake, K, Hossain, S A, Berclaz, P Y, Trapnell, B C
Published in Journal of Virology (01.10.2000)

Get full text

Journal Article

Initiation of prandial insulin therapy with AIR inhaled insulin or insulin lispro in patients with type 2 diabetes: A randomized noninferiority trial

Initiation of prandial insulin therapy with AIR inhaled insulin or insulin lispro in patients with type 2 diabetes: A randomized noninferiority trial

by Gross, Jorge L, Nakano, Masako, Colon-Vega, Gildred, Ortiz-Carasquillo, Ramon, Ferguson, Jeffrey A, Althouse, Sandra, Tobian, Janet A, Berclaz, Pierre-Yves, Milicevic, Zvonko
Published in Diabetes technology & therapeutics (01.09.2009)

Get more information

Journal Article

Two-year efficacy and safety of AIR inhaled insulin in patients with type 1 diabetes: An open-label randomized controlled trial

Two-year efficacy and safety of AIR inhaled insulin in patients with type 1 diabetes: An open-label randomized controlled trial

by Garg, Satish K, Mathieu, Chantal, Rais, Nadeem, Gao, Haitao, Tobian, Janet A, Gates, Jeffrey R, Ferguson, Jeffrey A, Webb, David M, Berclaz, Pierre-Yves
Published in Diabetes technology & therapeutics (01.09.2009)

Get more information

Journal Article